Time to renounce Arcadia Biosciences Inc. (NASDAQ:RKDA)?


Arcadia Biosciences, Inc. (NASDAQ:RKDA) stock had a weekly volatility of 10.16% and a monthly volatility of 7.11%. Arcadia Biosciences, Inc. RKDA shares float stands at 10.82M.

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction. Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

Recently, Arcadia Biosciences, Inc. (NASDAQ:RKDA) reported that Arcadia Biosciences, Inc. quarterly Return on Assets is -31.50%, while quarterly Return on Equity was -75.10% and quarterly Return on Investment was -39.40%.

Gross Margin in the past quarter was 74.50%. Current ratio was 9.80 while quick ratio was 9.70.

The firm’s Total Debt/Equity stood at 1.37 while Long Term Debt/Equity was 1.26.

The firm’s stock 50-Day High is $-32.94% and a 50-Day Low of $-6.56%. 20-Day Simple Moving Average was $-19.50% while 50-Day SMA was $-23.04%.

The firm announced EPS of $-0.42. This shows an EPS growth quarter over last quarter was 19.00%. EPS for the year was $5.60%. For the last 5-year, the stock has recorded an average EPS growth of -% and EPS growth for imminent year is projected to be 48.80% while EPS growth for the coming five years will be 14.96%.

The firm’s monthly average volume for the reported quarter was 33.28K and 33.28K for the full fiscal year. The relative volume was 2.24 for the quarter and 2.24 for the full fiscal year.

The stock’s 50-Day High in the last quarter was $-32.94% while the 50-Day Low was $-6.56%. In the last fiscal year, the stock hit a 52-Week High of $-79.27% and a 52-Week Low of $-6.56%.

The firm’s insider ownership was 52.03% and institutional ownership was 12.20%. Total institutional transactions amounted to -6.19%. Sales growth QoQ was 11.10%.